SCHEMBL813440

SCHEMBL813440

CC(=O)N(S)S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10918764 0.78
SCHEMBL19092117 0.78
SCHEMBL7050899 0.78
Acetic Acid SCHEMBL3803563 0.75 FFAR3 (0.54)
SCHEMBL20997524 0.68
SCHEMBL867771 0.67 LMNA (0.46)
SCHEMBL9504676 0.67 LMNA (0.46)
SCHEMBL16862643 0.67
SCHEMBL21328 0.67
SCHEMBL173293 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109096261-A A kind of preparation method of Fimasartan 四川海思科制药有限公司 2018-12-28 CN claimed
US-4009297-A Gold deposition procedures and substrates upon which gold has been deposited AMP INCORPORATED (US) 1977-02-22 US claimed
JP-7126244-A None JP disclosed
WO-2024056771-A1 RESIST COMPOSITION, METHOD FOR MANUFACTURING RESIST FILM, AND METHOD FOR MANUFACTURING DEVICE MERCK PATENT GMBH (DE) 2024-03-21 WO disclosed
EP-4025211-A1 METHODS OF TREATING EPILEPSY USING THE SAME Trevena, Inc. (US) 2022-07-13 EP disclosed
WO-2021046183-A1 METHODS OF TREATING EPILEPSY USING THE SAME TREVENA, INC. (US) 2021-03-11 WO disclosed
US-10100249-B2 Phosphor and method for manufacturing the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-10-16 US disclosed
CN-105837514-B The preparation method of Fimasartan impurity of the drug 北京睿创康泰医药研究院有限公司 2018-09-18 CN disclosed
CN-108012568-A Perovskite-based solar cell using graphene as transparent conductive electrode 多次元能源系统研究集团 2018-05-08 CN disclosed
US-20170137708-A1 PHOSPHOR AND METHOD FOR MANUFACTURING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-05-18 US disclosed
EP-3080115-A1 FUSED IMIDAZOLE AND PYRAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY UCB Biopharma SPRL (BE) 2016-10-19 EP disclosed
WO-2014076111-A1 N-(PYRIDIN-2-YL)PYRIMIDIN-4-AMINE DERIVATIVES CONTAINING A SULFOXIMINE GROUP BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-05-22 WO disclosed
CN-102552237-A Pharmaceutical composition and health food for preventing hepatic fibrosis or liver cirrhosis SEKISUI PLASTICS 2012-07-11 CN disclosed
US-8058322-B2 Flame-retardant flexible polyurethane foam ICL-IP AMERICA INC. (US) 2011-11-15 US disclosed
US-20090281205-A1 Flame-retardant flexible polyurethane foam ICL-IP AMERICA INC. 2009-11-12 US disclosed
EP-1885788-A2 FLAME-RETARDANT FLEXIBLE POLYURETHANE FOAM Supresta LLC (US) 2008-02-13 EP disclosed
WO-2007001717-A9 FLAME-RETARDANT FLEXIBLE POLYURETHANE FOAM SUPRESTA LLC (US) 2007-05-24 WO disclosed
WO-2007001717-A2 FLAME-RETARDANT FLEXIBLE POLYURETHANE FOAM SUPRESTA LLC (US) 2007-01-04 WO disclosed
JP-H07126244-A IMPROVED PREPARATION OF THIO ACETAMIDE MONSANTO CO 1995-05-16 JP disclosed
EP-0287493-A2 Liver growth factor INSTITUTO LLORENTE, S.A. (ES) 1988-10-19 EP disclosed